Free Newsletter
Solution serializes, finds fakes
Oracle and New Momentum are collaborating to help drug makers combat counterfeits. The effort is expected to offer pharmaceutical companies the ability to track units through the supply chain as well as quickly find the fakes.
The enterprise software giant is developing a manufacturing solution that provides for the serialization of each sellable unit of a drug and the tracking of that unit through the supply chain via electronic pedigree. New Momentum, for its part, is integrating its real-time view of counterfeit suspects, which aids manufacturers in proactive anti-counterfeiting efforts while maintaining compliance with serialization and pedigree mandates.
"The best way to meet counterfeiting challenges is to integrate internal enterprise and supply chain data with external data on counterfeit suspects and activity," says New Momentum CEO Stuart Clifton.
Prototypes will be demonstrated next week at Oracle OpenWorld in San Francisco.
- here's the release
Related Articles:
Tech guns aim at counterfeiters
FDA seeks input on anticounterfeiting guidance
Anticounterfeiting group hits the fast lane
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
